In order to examine the association of statin intake with serum prostate specific antigen (PSA) levels, the development of PCa, and overall patient survival we analyzed the Swiss (Aarau) section of the European Randomized Study of Screening for Prostate Cancer (ERSPC) [9, 10, 11]. This evidence concerns the gene KLK3 and prostate cancer.